Since BIM can be transcriptionally activated by CHOP in UPR,[27] we examined CHOP mRNA levels after treatment with IRE1α inhibitors in four pancreatic cancer cell lines (MiaPaCa2, Panc0403, SU8686, AsPc1). The gene discussed is DDIT3; the disease is pancreatic neoplasm.